Background/Objectives: Amelanotic nodular mel-
INTRODUCTION
Amelanotic nodules encompass a diverse group of lesions, ranging from benign tumours to high-risk cancers. About half of nodular melanomas are predominantly pink or red. 1 These melanomas often have a nonspecific macroscopic appearance, and a recent study showed that lack of pigmentation was the strongest correlate of misdiagnosis. 2 This can lead to an obstructed pathway to diagnosis. 3 Over recent decades, there has been a progressive reduction in tumour thickness of superficial spreading melanomas, while the thickness of nodular melanomas has increased or remained stable. 4 Indeed, nodular melanomas are responsible for many more deaths than any other melanoma subtype. 5 Although rarer, Merkel cell carcinomas are also highly aggressive amelanotic tumours which often have nonspecific macroscopic features and are prone to misdiagnosis and belated diagnosis.
Dermoscopy has a proven track record of enhancing diagnostic accuracy for pigmented skin lesions. [7] [8] [9] Relatively fewer studies have reported on the value of dermoscopy in evaluating clinically nonpigmented nodules, including amelanotic nodular melanoma.
METHODS
Macroscopic and dermoscopic images for a series of 150 macroscopically amelanotic nodules, excised for histopathological diagnosis between September 2009 and September 2014, were collected from a tertiary dermatology referral centre and private dermatology practices in Australia. Malignant nodules eligible for inclusion were basal cell carcinoma (BCC), squamous cell carcinoma (SCC), keratoacanthoma (KA), amelanotic melanoma and Merkel cell carcinoma. Benign nodules that were eligible for inclusion were dermatofibroma, naevus, seborrhoeic keratosis and haemangioma. Institutional ethics committee approval was obtained.
Clinical data were obtained from medical records for all cases including age at diagnosis, sex, site and nodule diameter. Digital dermoscopic images were captured with a dermatoscope (DermLite DL3 dermatoscope, Heine, Herrsching, Germany) mounted on a digital camera (Cyber-shot DSC-W290, Sony Corporation, Tokyo, Japan). Tenfold magnification was used. Alcohol gel was used for immersion, and precautions were taken to reduce compression artefact. Lesions were excluded if there was pigmentation visible to the naked eye. It was acknowledged that some macroscopically amelanotic nodules would have pigmentation visible only under the dermatoscope and such nodules were included in the study and classified as micropigmented tumours.
All macroscopic and dermoscopic images were evaluated retrospectively by two examiners in consensus who were unaware of the histopathological diagnosis. First, the macroscopic image was viewed and the nodule was given a diagnosis of malignant or benign, followed by the presumed most likely diagnosis (unaided eye diagnosis). Following this, the dermoscopic image of the same nodule was viewed and the lesion was given a diagnosis of benign or malignant, followed by the presumed most likely diagnosis (dermoscopic diagnosis). To avoid bias, the examiners were blinded to clinical information such as demographic data and history so that the scoring of nodules was based purely on the macroscopic and dermoscopic images.
Next, the dermoscopic images were evaluated for the presence or absence of predetermined dermoscopic criteria. Vascular structures were defined as comma vessels, dotted (pinpoint) vessels, sharply focused arborizing vessels, linear irregular vessels, glomerular vessels, corkscrew vessels and milky red-pink areas, with polymorphous vascular pattern being any combination of two or more different types of vascular structures, according to previously described criteria. 10, 11 We also evaluated for white/yellow structures, and white lines, a term encompassing shiny white structures/chrysalis structures, shiny white blotches, white strands, short white lines and rosettes. We evaluated for the presence of keratin scale, central keratin mass, keratin pearls, white/yellow circles, white structureless areas, scar-like areas, milia-like cysts, comedo-like openings and collarette. Other dermoscopic features assessed included ulceration, lacunes/vascular lakes and pigmented structures. Diagnostic sensitivity and specificity were calculated for each type of nodule using both the unaided eye and dermoscopy. Confidence intervals were calculated according to the Wilson procedure with correction for continuity. A comparison of diagnostic sensitivity and specificity for unaided diagnosis compared with dermoscopic diagnosis was performed using the McNemar's test. All given P values were two-tailed, and a P value of less than 0.05 was regarded as indicating statistical significance. Statistical testing was performed using Stata version 12 (StataCorp LP, College Station, TX, USA) statistical software.
RESULTS
The nodules were excised from 150 individuals, with median age of 66 years (range 19-103 years). Ninety-eight (65%) were men. Nodules were located on the upper limb (27%), lower limb (27%), head and neck (26%) and trunk (20%). The median nodule diameter was 7 mm (range 6-30 mm). There were 123 malignant nodules; 27 amelanotic melanomas, six Merkel cell carcinomas, 39 nodular BCCs and 51 SCC/KAs. There were 27 benign nodules; nine dermatofibromas, eight nevi, five seborrhoeic keratoses and five hemangiomas.
In terms of classifying the nodules as malignant or benign, the specificity of dermoscopy (89%; 95% CI 71-98%) was superior to unaided eye diagnosis (67%; 95% CI 46-83%). The sensitivity of unaided eye (96%; 95% CI 91-99%) and dermoscopy (98%; 95% CI 94-100%) were similar.
In 29 instances (19%), using dermoscopy, the most likely diagnosis was changed from incorrect to correct. This included three nodules where dermoscopy allowed the diagnosis to be overturned from benign to malignant and seven nodules that were macroscopically incorrectly diagnosed as SCC or BCC when they were correctly identified as amelanotic melanomas with dermoscopy. There were no cases in which dermoscopy changed a correct diagnosis to an incorrect diagnosis.
Dermoscopy enhanced sensitivity for the diagnosis of amelanotic melanoma (P = 0.02) as well as SCC/KA (P = 0.01; Table 1 ). For the diagnosis of nodular BCC, dermoscopy improved specificity (P < 0.001) and there was a trend for it to improve sensitivity (P = 0.06).
Of the 33 nodules where dermoscopy provided an incorrect diagnosis, 29 were malignant. Misdiagnoses were most frequent for amelanotic melanomas (18) and Merkel cell carcinomas (6) ( Table 2) .
Polymorphous vessels were more common in more aggressive tumours (Table 3) . Seventy-six percent of amelanotic melanomas/Merkel cell carcinomas had polymorphous vessels compared with 38% of SCCs/KAs/BCCs and 22% benign nodules (P < 0.001). In addition to polymorphous vessels, other common features of nodular melanomas were linear irregular vessels (30%), milky red-pink areas (44%) and micropigmented structures (37%). In addition to polymorphous vessels, other common features of Merkel cell carcinomas were linear irregular vessels (83%), sharply focused arborizing vessels (50%) and milky red-pink areas (83%).
For SCC/KA, common dermoscopic features were keratin scale (75%), central keratin mass (47%), ulceration (41%) and white/yellow circles (31%). Characteristic features of nodular BCC were sharply focused arborizing vessels (79%) and micropigmented structures (44%).
DISCUSSION
A nonpigmented nodule may have a nonspecific appearance to the naked eye, presenting a broad range of diagnoses that include benign tumours, nonmelanoma skin cancers, nodular melanoma and Merkel cell carcinoma. 12 The differing prognostic and therapeutic implications of these diagnoses make distinction important, and yet misdiagnosis is alarmingly common. Amelanotic nodular melanoma is a particularly elusive diagnosis, with recent studies in a high prevalence setting finding, the diagnostic sensitivity was only 19%, with pathways to diagnosis obstructed by misdiagnosis and false reassurance. 2, 3 This is a dilemma given the rapid rate of growth and aggressive biological behaviour of nodular melanoma. In Australia, despite only comprising 14% of melanomas, nodular melanoma contributes to 43% of the melanoma mortality. 5 Similarly, Merkel cell carcinomas are highly aggressive amelanotic tumours that are prone to delayed and inaccurate clinical diagnosis. 6 This is a unique clinical study describing the utility of dermoscopy in a series of malignant and benign amelanotic nodules. The study provides evidence that dermoscopy improves diagnostic accuracy of amelanotic malignant nodules. Compared to naked eye examination, dermoscopy increased specificity from 67% to 89%. This supports the importance of dermoscopy as an important noninvasive tool in the assessment of every amelanotic malignant nodule. 13 However, despite improving diagnostic accuracy, amelanotic melanomas remain very difficult to diagnose. The low dermoscopic sensitivity of 33% emphasizes the pitfalls in the diagnosis of this challenging entity. Menzies and colleagues 13 devised a diagnostic algorithm for hypomelanotic or amelanotic melanoma that achieved sensitivity of 70% and specificity of 56%, which remained inferior to that of pigmented melanoma for which various dermoscopic methods have achieved diagnostic sensitivity greater than 80% and specificity greater than 70%.
14 While dermoscopic features of nonpigmented melanoma have now been better described, our findings demonstrate that these tumours continue to be frequently misdiagnosed. Consistent with the literature, dermoscopy improved the diagnostic sensitivity and specificity for BCC 15 and the diagnostic sensitivity for SCC/KA. 16 In some cases, pigmentation may be revealed on the dermoscopic view which is not visible on naked eye assessment. Indeed, dermoscopic micropigmentation was seen in 37% of melanomas and 44% of BCCs. The magnification afforded by the dermatoscope provided useful clues in the diagnosis of these lesions, with dermoscopy improving the diagnostic accuracy for micropigmented melanomas (diagnostic sensitivity 50% compared to 10% naked eye assessment) and for micropigmented BCCs (diagnostic sensitivity of 94% compared to 71% naked eye assessment).
Vascular morphology has been identified as an important dermoscopic diagnostic criterion when assessing nonpigmented lesions, and in our series, it helped distinguish malignant nodules from benign nodules. Different vascular structures are associated with different skin tumours, and polymorphous vascular morphology has been associated with amelanotic melanoma, Merkel cell carcinoma and SCC and BCC. 13, [15] [16] [17] [18] [19] Our results demonstrate that the polymorphous vascular pattern is more strongly associated 
with amelanotic melanoma and Merkel cell carcinoma compared with less aggressive skin cancers (SCC/KA and BCC). Ulceration was more common among malignant nodules compared with benign nodules, affirming that ulceration is a malignant feature. Many SCC/KAs had keratin scale or central keratin mass, both of which have been previously described as important dermoscopic clues. 20 Most BCCs had sharply focused arborizing vessels, a feature which was shown to occur more commonly among nonpigmented and lightly pigmented BCC. 15 Another important clue to nodule malignancy is the presence of white lines. These structures are often attributed to fibrosis and collagen remodelling in tumour stroma. 21 In nodular SCC/KA, it was common to observe keratin scale, central keratin mass, keratin pearls, white/ yellow circles, white structureless areas and collarette. In nodular BCC, we observed keratin scale, white lines, white structureless areas and scar-like areas. In amelanotic melanoma and Merkel cell carcinoma, it was common to find white lines and white structureless areas.
There were several limitations to our research. Our cohort contained selection biases as lesions were recruited retrospectively from multiple centres and were nonconsecutive. Also, although dermoscopy improved the specificity for the diagnosis of clinically amelanotic nodules in this study, the implications of this increased specificity are difficult to extrapolate based on the study design. The fact that all lesions were excised reflected clinical suspicion and we acknowledge this does not reflect the full range of pink or red nodules seen in clinical practice.
In conclusion, our findings suggest that dermoscopy improves the diagnostic accuracy of amelanotic nodules. Polymorphous vascular morphology may be a marker of tumour aggressiveness, more common in amelanotic melanoma and Merkel cell carcinoma than in other nodules. Dermoscopy should be used in the assessment of all amelanotic nodules and if deemed malignant, prompt excision is mandated. 
